By providing engineers with a new polymer tubing platform specifically designed for BRS applications, next-generation device designs and therapies that once seemed unimaginable are now within reach.
Continual improvements in minimally invasive therapies and stenting techniques have improved the lives of countless people suffering from atherosclerotic diseases such as CAD and PAD. Historically, metallic stents have been the go-to devices for these treatments. However, these devices are not without drawbacks. Adverse events such as restenosis or thrombosis at the permanent implant site, strut fracture, and interference with vessel compliance and vasomotion are all potential complications of metallic DES.
While first-generation bioresorbable vascular scaffolds sought to overcome many of these challenges, they suffered from fundamental limitations regarding strut thickness, limited over-expansion, and the requirement for special considerations in implantation techniques.
By studying the failures and building on the successes of the past, Zeus has developed an optimized polymer tubing platform specifically designed for bioresorbable scaffolds (BRS), helping to pave the way for next-generation therapies and improved patient outcomes.